Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Maternal hypertension, medication use, and hypospadias in the National Birth Defects Prevention Study.

Van Zutphen AR, Werler MM, Browne MM, Romitti PA, Bell EM, McNutt LA, Druschel CM, Mitchell AA; National Birth Defects Prevention Study.

Obstet Gynecol. 2014 Feb;123(2 Pt 1):309-17. doi: 10.1097/AOG.0000000000000103.

PMID:
24402588
2.

Maternal hypertension, antihypertensive medication use, and the risk of severe hypospadias.

Caton AR, Bell EM, Druschel CM, Werler MM, Mitchell AA, Browne ML, McNutt LA, Romitti PA, Olney RS, Correa A; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2008 Jan;82(1):34-40.

PMID:
18022875
3.

Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study.

van Gelder MM, Van Bennekom CM, Louik C, Werler MM, Roeleveld N, Mitchell AA.

BJOG. 2015 Jun;122(7):1002-9. doi: 10.1111/1471-0528.13138. Epub 2014 Nov 14.

4.

Beta-blockers increase the risk of being born small for gestational age or of being institutionalised during infancy.

Xie RH, Guo Y, Krewski D, Mattison D, Walker MC, Nerenberg K, Wen SW.

BJOG. 2014 Aug;121(9):1090-6. doi: 10.1111/1471-0528.12678. Epub 2014 Mar 17.

5.

Maternal Antihypertensive Medication Use and Congenital Heart Defects: Updated Results From the National Birth Defects Prevention Study.

Fisher SC, Van Zutphen AR, Werler MM, Lin AE, Romitti PA, Druschel CM, Browne ML; and the National Birth Defects Prevention Study.

Hypertension. 2017 May;69(5):798-805. doi: 10.1161/HYPERTENSIONAHA.116.08773. Epub 2017 Apr 3.

PMID:
28373593
6.

Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations.

Caton AR, Bell EM, Druschel CM, Werler MM, Lin AE, Browne ML, McNutt LA, Romitti PA, Mitchell AA, Olney RS, Correa A; National Birth Defects Prevention Study.

Hypertension. 2009 Jul;54(1):63-70. doi: 10.1161/HYPERTENSIONAHA.109.129098. Epub 2009 May 11.

7.

Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997-2007.

Lind JN, Tinker SC, Broussard CS, Reefhuis J, Carmichael SL, Honein MA, Olney RS, Parker SE, Werler MM; National Birth Defects Prevention Study.

Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):783-93. doi: 10.1002/pds.3448. Epub 2013 Apr 26.

8.

Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns.

Nakhai-Pour HR, Rey E, Bérard A.

Birth Defects Res B Dev Reprod Toxicol. 2010 Apr;89(2):147-54. doi: 10.1002/bdrb.20238.

PMID:
20437474
9.

Oral beta-blockers for mild to moderate hypertension during pregnancy.

Magee LA, Duley L.

Cochrane Database Syst Rev. 2000;(4):CD002863. Review. Update in: Cochrane Database Syst Rev. 2003;(3):CD002863.

PMID:
11034777
10.

Maternal occupational pesticide exposure and risk of hypospadias in the National Birth Defects Prevention Study.

Rocheleau CM, Romitti PA, Sanderson WT, Sun L, Lawson CC, Waters MA, Stewart PA, Olney RS, Reefhuis J.

Birth Defects Res A Clin Mol Teratol. 2011 Nov;91(11):927-36. doi: 10.1002/bdra.22860. Epub 2011 Sep 22.

PMID:
21954192
11.

Development: Hypospadias linked with maternal hypertension.

Greenhill C.

Nat Rev Endocrinol. 2014 Apr;10(4):189. doi: 10.1038/nrendo.2014.5. Epub 2014 Jan 28. No abstract available.

PMID:
24468650
12.

No association between maternal pre-pregnancy obesity and risk of hypospadias or cryptorchidism in male newborns.

Adams SV, Hastert TA, Huang Y, Starr JR.

Birth Defects Res A Clin Mol Teratol. 2011 Apr;91(4):241-8. doi: 10.1002/bdra.20805. Epub 2011 Apr 1.

13.

Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes.

Orbach H, Matok I, Gorodischer R, Sheiner E, Daniel S, Wiznitzer A, Koren G, Levy A.

Am J Obstet Gynecol. 2013 Apr;208(4):301.e1-6. doi: 10.1016/j.ajog.2012.11.011. Epub 2012 Nov 15.

PMID:
23159698
14.

Antihypertensive medication use and risk of renal cell carcinoma.

Colt JS, Hofmann JN, Schwartz K, Chow WH, Graubard BI, Davis F, Ruterbusch J, Berndt S, Purdue MP.

Cancer Causes Control. 2017 Apr;28(4):289-297. doi: 10.1007/s10552-017-0857-3. Epub 2017 Feb 21.

PMID:
28224412
15.

Oral beta-blockers for mild to moderate hypertension during pregnancy.

Magee LA, Duley L.

Cochrane Database Syst Rev. 2003;(3):CD002863. Review.

PMID:
12917933
16.

Drug treatment of hypertension in pregnancy: a critical review of adult guideline recommendations.

Al Khaja KA, Sequeira RP, Alkhaja AK, Damanhori AH.

J Hypertens. 2014 Mar;32(3):454-63. doi: 10.1097/HJH.0000000000000069. Review.

PMID:
24384846
17.

Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis.

Lee S, Hess EP, Nestler DM, Bellamkonda Athmaram VR, Bellolio MF, Decker WW, Li JT, Hagan JB, Manivannan V, Vukov SC, Campbell RL.

J Allergy Clin Immunol. 2013 Apr;131(4):1103-8. doi: 10.1016/j.jaci.2013.01.011. Epub 2013 Feb 27.

PMID:
23453138
18.

Beta-blockers for hypertension.

Wiysonge CS, Bradley H, Mayosi BM, Maroney R, Mbewu A, Opie LH, Volmink J.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002003. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD002003.

PMID:
17253471
19.

Treating hypertension in women of child-bearing age and during pregnancy.

Magee LA.

Drug Saf. 2001;24(6):457-74. Review.

PMID:
11368252
20.

Differences in risk factors for second and third degree hypospadias in the national birth defects prevention study.

Woud SG, van Rooij IA, van Gelder MM, Olney RS, Carmichael SL, Roeleveld N, Reefhuis J; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2014 Sep;100(9):703-11. doi: 10.1002/bdra.23296. Epub 2014 Sep 2.

Supplemental Content

Support Center